120410-24-4

120410-24-4 structure
120410-24-4 structure
  • Name: Biapenem
  • Chemical Name: biapenem
  • CAS Number: 120410-24-4
  • Molecular Formula: C15H18N4O4S
  • Molecular Weight: 350.393
  • Catalog: API Synthetic anti-infective drugs Antifungal drugs
  • Create Date: 2018-05-11 08:00:00
  • Modify Date: 2026-06-30 17:17:14
  • Biapenem is a parenteral carbapenem antibacterial agent with a broad spectrum.Target: AntibacterialBiapenem is a carbapenem antibiotic of in vitro antibacterial activity encompassing many Gramnegative and Gram-positive aerobic and anaerobic bacteria, including species producing β-lactamases. Biapenem is more stable than imipenem, mero-penem and panipenem to hydrolysis by human renal dihydropeptidase-I (DHP-I), and therefore does not require the coadministration of a DHP-I inhibitor. In randomised, nonblind or double-blind clinical trials, biapenem showed good clinical and bacteriological efficacy (similar to that of imipenem/ cilastatin) in the treatment of adult patients with intra-abdominal infections, lower respiratory infections or complicated urinary tract infections.

Name biapenem
Synonyms Biapenem (JAN/USAN)
6-{[(4R,5S,6S)-2-cboxylato-6-[(1R)-1-hydroxyethyl]-4-Methyl-7-oxo-1-azabicyclo[3.2.0]ht-2-en-3-yl]sulfanyl}-5H,6H,7H-2
LJC-10627
Biapenem for Injection
BiapenemQ: What is Biapenem Q: What is the CAS Number of Biapenem Q: What is the storage condition of Biapenem Q: What e the applications of Biapenem
Biapenem, >=
l^{5},2,4]triazol-4-yliuM
Biapenem Impurity 13
l^{5},8000000-pyrazolo[1,2-a][1
L-627; LJC
Biapenem [USAN:INN]
Biapenem Powder Standd
(4R,5S,6S)-3-(6,7-Dihydro-5H-pyrazolo[1,2-a][1,2,4]triazol-4-ium-6-ylsulfanyl)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
[4R-[4a,5b,6b(R*)]]-6-[[2-Carboxy-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]thio]-6,7-dihydro-5 H-pyrazolo[1,2-a][1,2,4]triazol-4-ium inner salt
Biapenem (GMP)
Biapenem //BP
Biapenem AKSci M048
omegacin
MFCD00864863
BiapeneM
Biapenem Powder
LJ C10,627
Biapenern
(4R,5S,6S)-3-(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazol-4-ium-6-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]ht-2-ene-2-cboxylate
6-(7-oxo-1-azabicyclo[3.2.0]ht-2-en-6-yl)-1-azabicyclo[3.2.0]ht-2-en-7-one
6-[[(4R,5S,6S)-2-Cboxylato-6β-[(R)-1-hydroxyethyl]-4α-methyl-7-oxo-1-azabicyclo[3.2.0]ht-2-en-3-yl]thio]-6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazol-4-ium
6-[[(4r,5s,6s)-2-cboxy-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]ht-2-en-3-yl]thio]-6,7-dihydro-5h-pyrazolo[1,2-a][1,2,4]triazol-4-ium inner salt
6-[[(4R,5β)-2-Cboxylato-4α-methyl-6β-[(R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]ht-2-en-3-yl]thio]-6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazol-4-ium
protected biapenum
Crude
6-[[(4R,5S,6S)-2-Cboxylato-6β-[(1R)-1-hydroxyethyl]-4α-Methyl-7-oxo-1-azabicyclo[3.2.0]he
ade
OMegacin
EINECS 204-352-8
5H-Pyrazolo[1,2-a][1,2,4]triazol-4-ium, 6-[[(4R,5S,6S)-2-carboxy-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]thio]-6,7-dihydro-, inner salt
BiapeneM Crude
protected biapenem
LJ C10627
Biapenem Biapenem
(4R,5S,6S)-3-((6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazol-4-ium-6-yl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]ht-2-ene-2-cboxylate
(155-9) biapenem
L-627
6-[[(4R,5S,6S)-2-Cboxylato-6β-[(1R)-1-hydroxyethyl]-4α-methyl-7-oxo-1-azabicyclo[3.2.0]ht-2-en-3-yl]thio]-6,7-dihydro-5H-pyrazolo[1,2-a]-s-triazol-4-ium
5H-Pyrazolo[1,2-a][1,2,4]triazol-4-ium, 6-[[(4R,5S,6S)-2-cboxy-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]ht-2-en-3-yl]thio]-6,7-dihydro-, inner salt
Description Biapenem is a parenteral carbapenem antibacterial agent with a broad spectrum.Target: AntibacterialBiapenem is a carbapenem antibiotic of in vitro antibacterial activity encompassing many Gramnegative and Gram-positive aerobic and anaerobic bacteria, including species producing β-lactamases. Biapenem is more stable than imipenem, mero-penem and panipenem to hydrolysis by human renal dihydropeptidase-I (DHP-I), and therefore does not require the coadministration of a DHP-I inhibitor. In randomised, nonblind or double-blind clinical trials, biapenem showed good clinical and bacteriological efficacy (similar to that of imipenem/ cilastatin) in the treatment of adult patients with intra-abdominal infections, lower respiratory infections or complicated urinary tract infections.
Related Catalog
References

[1]. Perry, C.M. and T. Ibbotson, Biapenem. Drugs, 2002. 62(15): p. 2221-34; discussion 2235.

[2]. Kasahara, S., et al., [Clinical effects of biapenem on febrile neutropenia in patients with hematological malignancy]. Jpn J Antibiot, 2008. 61(3): p. 115-21.

Melting Point 265-271°C (dec.)
Molecular Formula C15H18N4O4S
Molecular Weight 350.393
Exact Mass 350.104889
PSA 127.67000
Index of Refraction 1.651
Storage condition -20?C Freezer
RIDADR NONH for all modes of transport
Precursor  2

DownStream  0

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.